TY - JOUR
T1 - Management of ALL in adults
T2 - 2024 ELN recommendations from a European expert panel
AU - Gökbuget, Nicola
AU - Boissel, Nicolas
AU - Chiaretti, Sabina
AU - Dombret, Hervé
AU - Doubek, Michael
AU - Fielding, Adele
AU - Foà, Robin
AU - Giebel, Sebastian
AU - Hoelzer, Dieter
AU - Hunault, Mathilde
AU - Marks, David I.
AU - Martinelli, Giovanni
AU - Ottmann, Oliver
AU - Rijneveld, Anita
AU - Rousselot, Philippe
AU - Ribera, Josep
AU - Bassan, Renato
N1 - Publisher Copyright:
© 2024 American Society of Hematology
PY - 2024/5/9
Y1 - 2024/5/9
N2 - Experts from the European Leukemia Net (ELN) working group for adult acute lymphoblastic leukemia have identified an unmet need for guidance regarding management of adult acute lymphoblastic leukemia (ALL) from diagnosis to aftercare. The group has previously summarized their recommendations regarding diagnostic approaches, prognostic factors, and assessment of ALL. The current recommendation summarizes clinical management. It covers treatment approaches, including the use of new immunotherapies, application of minimal residual disease for treatment decisions, management of specific subgroups, and challenging treatment situations as well as late effects and supportive care. The recommendation provides guidance for physicians caring for adult patients with ALL which has to be complemented by regional expertise preferably provided by national academic study groups.
AB - Experts from the European Leukemia Net (ELN) working group for adult acute lymphoblastic leukemia have identified an unmet need for guidance regarding management of adult acute lymphoblastic leukemia (ALL) from diagnosis to aftercare. The group has previously summarized their recommendations regarding diagnostic approaches, prognostic factors, and assessment of ALL. The current recommendation summarizes clinical management. It covers treatment approaches, including the use of new immunotherapies, application of minimal residual disease for treatment decisions, management of specific subgroups, and challenging treatment situations as well as late effects and supportive care. The recommendation provides guidance for physicians caring for adult patients with ALL which has to be complemented by regional expertise preferably provided by national academic study groups.
UR - http://www.scopus.com/inward/record.url?scp=85186675398&partnerID=8YFLogxK
U2 - 10.1182/blood.2023023568
DO - 10.1182/blood.2023023568
M3 - Comment/Letter to the editor
C2 - 38306595
AN - SCOPUS:85186675398
SN - 0006-4971
VL - 143
SP - 1903
EP - 1930
JO - Blood
JF - Blood
IS - 19
ER -